Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum
23 janv. 2019 07h30 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
Nemus Bioscience to Present at the 2nd Annual Sach’s Neuroscience Innovation Forum and Biotech Showcase 2019
03 janv. 2019 07h00 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
Nemus Bioscience to Present at Investment and Scientific Conferences in December
29 nov. 2018 15h51 HE
|
Nemus Bioscience, Inc.
Long Beach, CA, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
Nemus Bioscience to Present at BIO Investor Forum
15 oct. 2018 08h30 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares
08 oct. 2018 08h00 HE
|
Nemus Bioscience, Inc.
Avtar Dhillon, MD, appointed as Executive Chairman of Nemus LONG BEACH, CA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the...
NEMUS Bioscience to Present at The MicroCap Conference
26 sept. 2018 08h00 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
NEMUS Bioscience to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
28 août 2018 08h00 HE
|
Nemus Bioscience, Inc.
Long Beach, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
01 août 2018 09h54 HE
|
Nemus Bioscience, Inc.
Long Beach, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
01 août 2018 08h30 HE
|
Nemus Bioscience, Inc.
Long Beach, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Nemus Bioscience to Participate at the 8th Annual LD Micro Invitational
30 mai 2018 08h30 HE
|
Nemus Bioscience, Inc.
LONG BEACH, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...